glp-1 trials Discover How Are Not One-Size-Fit-All Summaries of landmark trials with

doi: 10.1016/j.eclinm.2024.103029 6 BhardwajS.PathakK.McLenonM.SpectorS.TuK

Simple metabolic reset found to prevent weight rebound after discontinuing GLP-1 drugs Minimally invasive endoscopic procedure may offer lasting weight loss maintenance, scientists say Bookmark CommentsGo to comments A simple outpatient procedure may provide a majority of people who discontinue popular weight-loss drugs a way to prevent regaining their lost pounds, scientists reveal in a new study

review of literature Given the pathophysiological heterogeneity of HFpEF, our understanding has been constrained by limited access to human samples and the absence of animal models that fully replicate the human HFpEF phenotype

In 2014, the FDA and the EMA found no causal association between GLP-1RA and pancreatic adverse events (67)

Toxins 2017;9